Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
The President's Malaria Initiative; seventh annual report to Congress
  • Published Date:
    April 2013
Filetype[PDF-35.36 MB]

This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
The President's Malaria Initiative; seventh annual report to Congress
  • Alternative Title:
  • Description:
    Executive summary -- 1. Outcomes and impact -- 2. Malaria prevention -- 3. Malaria diagnosis and treatment -- 4. Global and U.S. government partnerships -- 5. Malaria research and innovation -- Appendix 1. PMI funding FYs 2006-2012 -- Appendix 2. PMI contribution summary -- Appendix 3. PMI Country-level targets -- Abbreviations and acronyms

    The past decade has seen unprecedented progress in malaria control efforts in most sub-Saharan African countries. As countries have scaled up insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS), improved diagnostic tests and highly effective antimalarial drugs, mortality in children under five years of age has fallen dramatically. It is now clear that the cumulative efforts and funding by the President's Malaria Initiative (PMI), national governments, The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), the World Bank and many other donors are working: The risk of malaria is declining. According to the World Health Organization's (WHO's) The U.S. Government's financial and technical contributions have played a major role in this remarkable progress. However, gaps in resources remain. If progress is to be sustained, committed efforts must continue. The theme for World Malaria Day 2013, and for the years leading up to the 2015 target date for the Millennium Development Goals, is "Invest in the future. Defeat malaria." To this end, PMI and partners continue to build on investments in malaria control and prevention and respond to challenges, such as antimalarial drug resistance, insecticide resistance and weak malaria case surveillance.

  • Document Type:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: